{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:13:17Z","timestamp":1791400397159,"version":"4.3.3"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2008,4,9]],"date-time":"2008-04-09T00:00:00Z","timestamp":1207699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4,9]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>There are no epidemiological studies from the British Isles of chronic granulomatous disease, characterized by recurrent, life-threatening bacterial and fungal infections and inflammatory sequelae. Patients were enrolled in a national registry and medical records were analysed. Of 94 subjects, 69 had X-linked disease, 16 had autosomal recessive disease and nine were unknown. Prevalence was 7\u00b75\/million for 1990\u201399 and 8\u00b75\/million for 1980\u201389. Suppurative adenitis, abscesses and pneumonia presented commonly. Twenty-three of 30 patients who underwent high resolution computerized tomography had chronic respiratory disease. Inflammatory sequelae included bowel stricture and urogenital tract granulomata. Growth failure was common; 75% of those measured were below the population mean. All patients received prophylactic antibiotics and 93% anti-fungal prophylaxis. Interferon gamma was used to treat infection, but rarely as prophylaxis. Despite prophylaxis, estimated survival was 88% at 10\u2003years but 55% at age 30\u2003years. Morbidity remains significant, severe infectious complications common. Curative treatments including stem cell transplantation should be considered for patients with frequent or serious complications.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2008.03644.x","type":"journal-article","created":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T09:53:37Z","timestamp":1280224417000},"page":"211-218","source":"Crossref","is-referenced-by-count":214,"title":["Special Article: Chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry"],"prefix":"10.1093","volume":"152","author":[{"given":"L B K R","family":"Jones","sequence":"first","affiliation":[{"name":"School of Clinical Medical Sciences, Child Health, University of Newcastle upon Tyne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"McGrogan","sequence":"additional","affiliation":[{"name":"School of Clinical Medical Sciences, Child Health, University of Newcastle upon Tyne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T J","family":"Flood","sequence":"additional","affiliation":[{"name":"Newcastle General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A R","family":"Gennery","sequence":"additional","affiliation":[{"name":"School of Clinical Medical Sciences, Child Health, University of Newcastle upon Tyne"},{"name":"Newcastle General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Morton","sequence":"additional","affiliation":[{"name":"Great Ormond Street Hospital for Children, Newcastle upon Tyne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Thrasher","sequence":"additional","affiliation":[{"name":"Great Ormond Street Hospital for Children, Newcastle upon Tyne"},{"name":"Institute of Child Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Goldblatt","sequence":"additional","affiliation":[{"name":"Great Ormond Street Hospital for Children, Newcastle upon Tyne"},{"name":"Institute of Child Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Parker","sequence":"additional","affiliation":[{"name":"School of Clinical Medical Sciences, Child Health, University of Newcastle upon Tyne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Cant","sequence":"additional","affiliation":[{"name":"School of Clinical Medical Sciences, Child Health, University of Newcastle upon Tyne"},{"name":"Newcastle General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,4,9]]},"reference":[{"key":"2022010405162194500_b1","first-page":"309","article-title":"A fatal granulomatosus of childhood","volume":"40","author":"Berendes","year":"1957","journal-title":"Minn Med"},{"key":"2022010405162194500_b2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1542\/peds.20.3.431","article-title":"A syndrome of recurrent infection and infiltration of viscera by pigmented lipid histiocytes","volume":"20","author":"Landing","year":"1957","journal-title":"Pediatrics"},{"key":"2022010405162194500_b3","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(76)93021-X","article-title":"Characterisation of the enzyme defect in chronic granulomatous disease","volume":"1","author":"Segal","year":"1976","journal-title":"Lancet"},{"key":"2022010405162194500_b4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJM197403142901104","article-title":"Defective superoxide production by granulocytes from patients with chronic granulomatous disease","volume":"290","author":"Curnutte","year":"1974","journal-title":"N Engl J Med"},{"key":"2022010405162194500_b5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/327717a0","article-title":"The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex","volume":"327","author":"Dinauer","year":"1987","journal-title":"Nature"},{"key":"2022010405162194500_b6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood.V77.4.673.673","article-title":"Molecular basis of chronic granulomatous disease","volume":"77","author":"Smith","year":"1991","journal-title":"Blood"},{"key":"2022010405162194500_b7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00005792-200005000-00004","article-title":"Genetic, biochemical and clinical features of chronic granulomatous disease","volume":"79","author":"Segal","year":"2000","journal-title":"Medicine"},{"key":"2022010405162194500_b8","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nature02356","article-title":"The large-conductance Ca2+-activated K+ channel is essential for innate immunity","volume":"427","author":"Ahluwalia","year":"2004","journal-title":"Nature"},{"key":"2022010405162194500_b9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3476(89)80693-6","article-title":"Incidence, severity, and prevention of infections in chronic granulomatous disease","volume":"114","author":"Mouy","year":"1989","journal-title":"J Pediatr"},{"key":"2022010405162194500_b10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.2000.01314.x","article-title":"Chronic granulomatous disease","volume":"122","author":"Goldblatt","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"2022010405162194500_b11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00279395","article-title":"Chronic granulomatous disease, a heterogeneous syndrome","volume":"64","author":"Hitzig","year":"1983","journal-title":"Hum Genet"},{"key":"2022010405162194500_b12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM197302222880802","article-title":"Gastrointestinal manifestations of chronic granulomatous disease","volume":"288","author":"Ament","year":"1973","journal-title":"N Engl J Med"},{"key":"2022010405162194500_b13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/adc.84.2.147","article-title":"Colitis in chronic granulomatous disease","volume":"84","author":"Schappi","year":"2001","journal-title":"Arch Dis Child"},{"key":"2022010405162194500_b14","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1542\/peds.114.2.462","article-title":"Gastrointestinal involvement in chronic granulomatous disease","volume":"114","author":"Marciano","year":"2004","journal-title":"Pediatrics"},{"key":"2022010405162194500_b15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood.V48.2.309.309","article-title":"The biochemical basis of nitroblue tetrazlium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes","volume":"48","author":"Baehner","year":"1976","journal-title":"Blood"},{"key":"2022010405162194500_b16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0022-1759(94)00247-T","article-title":"Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes","volume":"178","author":"Vowells","year":"1995","journal-title":"J Immunol Methods"},{"key":"2022010405162194500_b17","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/adc.65.9.942","article-title":"Prognosis of chronic granulomatous disease","volume":"65","author":"Finn","year":"1990","journal-title":"Arch Dis Child"},{"key":"2022010405162194500_b18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(96)90403-1","article-title":"Chronic granulomatous disease in adults","volume":"347","author":"Liese","year":"1996","journal-title":"Lancet"},{"key":"2022010405162194500_b19","first-page":"351","article-title":"Follow up of patients with chronic granulomatous disease diagnosed since","volume":"120","author":"Cale","year":"1990","journal-title":"Clin Exp Immunol 2000 since"},{"key":"2022010405162194500_b20","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1651-2227.1995.tb13575.x","article-title":"Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden","volume":"84","author":"Ahlin","year":"1995","journal-title":"Acta Paediatrica"},{"key":"2022010405162194500_b21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","article-title":"Chronic granulomatous disease. Report on a national registry of 368 patients","volume":"79","author":"Winkelstein","year":"2000","journal-title":"Medicine"},{"key":"2022010405162194500_b22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1442-200x.1999.01129.x","article-title":"Chronic granulomatous disease in Japan: incidence and natural history","volume":"41","author":"Hasui","year":"1999","journal-title":"Pediatr Int"},{"key":"2022010405162194500_b23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/A:1020660416865","article-title":"Primary immunodeficiency in Iran: first report of the national registry of PID in children and adults","volume":"22","author":"Aghamohammadi","year":"2002","journal-title":"J Clin Immunol"},{"key":"2022010405162194500_b24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2007.09.008","article-title":"Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study","volume":"126","author":"Martire","year":"2008","journal-title":"Clin Immunol"},{"key":"2022010405162194500_b25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0022-3476(85)80626-0","article-title":"Clinical differences in chronic granulomatous disease in patients with cytochrome b-negative or cytochrome b positive neutrophils","volume":"107","author":"Weening","year":"1985","journal-title":"J Pediatr"},{"key":"2022010405162194500_b26","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/BF01957525","article-title":"The management of chronic granulomatous disease","volume":"152","author":"Fischer","year":"1993","journal-title":"Eur J Pediatr"},{"key":"2022010405162194500_b27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199102213240801","article-title":"A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease","volume":"324","author":"Ezekowitz","year":"1991","journal-title":"N Engl J Med"},{"key":"2022010405162194500_b28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1157\/13106774","article-title":"Chronic granulomatous disease in pediatric patients: 25 years of experience","volume":"35","author":"Soler-Palac\u00edn","year":"2007","journal-title":"Allergol Immunopathol (Madr)"},{"key":"2022010405162194500_b29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1067\/mpd.2000.109112","article-title":"Long-term follow-up and outcome of 39 patients with chronic granulomatous disease","volume":"137","author":"Liese","year":"2000","journal-title":"J Pediatr"},{"key":"2022010405162194500_b30","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1056\/NEJM200103223441203","article-title":"Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft","volume":"344","author":"Horwitz","year":"2001","journal-title":"N Engl J Med"},{"key":"2022010405162194500_b31","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1182\/blood-2002-02-0583","article-title":"Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985\u20132000","volume":"100","author":"Seger","year":"2002","journal-title":"Blood"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03644.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03644.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/152\/2\/211\/42041653\/j.1365-2249.2008.03644.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/152\/2\/211\/42041653\/j.1365-2249.2008.03644.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T05:21:16Z","timestamp":1641273676000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/152\/2\/211\/6457575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,9]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2008,4,9]]},"published-print":{"date-parts":[[2008,4,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03644.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,5]]},"published":{"date-parts":[[2008,4,9]]}}}